3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
7
Recurrence
1
Purpura
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Nausea
1
Macroglossia
1
Lymphoma
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Immunoglobulin Light-chain Amyloidosis
1
Hepatomegaly
1
Hematologic Neoplasms
1
Gastrointestinal Hemorrhage
1
Diarrhea
1
Constipation
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Lenalidomide
8
Dexamethasone
6
Calcium Dobesilate
6
Melphalan
3
elotuzumab
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
daratumumab
2
auricularum
2
Peripheral Blood Stem Cell Transplantation
2
Bortezomib
2
pomalidomide
1
piperine
1
pembrolizumab
1
ixazomib
1
ibrutinib
1
Watchful Waiting
1
Urination
1
Transplantation, Autologous
1
Stem Cell Transplantation
1
Receptors, Interleukin-6
1
Observation
1
Nivolumab
1
Metformin
1
Interleukin 1 Receptor Antagonist Protein
1
In Situ Hybridization, Fluorescence
1
IPH-2101
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Smoldering Multiple Myeloma
×
isatuximab
×
Clear all
No trials found.